New hope for blood cancer patients: STP938 trial targets tough cases

NCT ID NCT06786234

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 2 trial tests STP938, a daily pill, in 50 adults with high-risk essential thrombocythaemia who cannot use standard therapy. The goal is to see if it safely lowers high platelet counts and reduces complications like blood clots. Participants take the drug for up to 12 months with regular clinic visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
STP938
What this could lead to
If it works, this could offer a new treatment option for people with essential thrombocythaemia who cannot take or do not respond to current therapy.
What could go wrong
This is an early Phase 2 trial with only 50 participants, so results may not apply to everyone. The drug may cause side effects or fail to control platelet counts long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL THROMBOCYTHAEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Brest

    RECRUITING

    Brest, France

  • CHU Nantes

    RECRUITING

    Nantes, France

  • CHU Nice

    RECRUITING

    Nice, France

  • CHU Nîmes

    RECRUITING

    Nîmes, France

  • Cancer and Haematology Centre, Churchill Hospital

    RECRUITING

    Oxford, OX3 7LE, United Kingdom

  • Gustave Roussy

    RECRUITING

    Villejuif, France

  • Hôpital Saint-Louis

    RECRUITING

    Paris, France

  • Hôpital de la Milétrie, CHU

    NOT_YET_RECRUITING

    Poitiers, New Aquitaine, 86021, France

  • Imperial College London / Hammersmith Hospital

    RECRUITING

    London, United Kingdom

  • Institut Paoli-Calmettes

    RECRUITING

    Marseille, France

  • Royal Hallamshire Hospital

    RECRUITING

    Sheffield, South Yorkshire, S10 2JF, United Kingdom

  • Sarah Cannon Research Institute

    RECRUITING

    London, United Kingdom

  • University Hospital of Wales

    RECRUITING

    Cardiff, United Kingdom

  • University of Southampton Hospital

    RECRUITING

    Southampton, United Kingdom